Immutep

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). 

CEO
Marc Voigt
CEOMarc Voigt
Employees
Employees
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1987
Founded1987
Employees
Employees

IMMP Key Statistics

Market cap
88.87M
Market cap88.87M
Price-Earnings ratio
-1.67
Price-Earnings ratio-1.67
Dividend yield
Dividend yield
Average volume
78.85M
Average volume78.85M
High today
$0.6258
High today$0.6258
Low today
$0.585
Low today$0.585
Open price
$0.6101
Open price$0.6101
Volume
2.81M
Volume2.81M
52 Week high
$3.53
52 Week high$3.53
52 Week low
$0.2928
52 Week low$0.2928

IMMP News

TipRanks 5d
Immutep Wins FDA Orphan Drug Status for Eftilagimod Alfa in Soft Tissue Sarcoma

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Benzinga 6d
Immutep Gets FDA Boost For Lead Cancer Drug, Stock Doubles

Immutep is a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. The company is focused on therapeutics r...

Immutep Gets FDA Boost For Lead Cancer Drug, Stock Doubles
TipRanks 6d
Why Is Immutep Stock Up Today?

Immutep (IMMP) stock rocketed higher on Wednesday after the biotechnology company announced that the U.S. Food and Drug Administration (FDA) has granted eftilag...

Analyst ratings

67%

of 6 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

More IMMP News

TipRanks 6d
Immutep granted Orphan Drug Designation for eftilagimod alfa

Immutep (IMMP) announced that the FDA has granted Orphan Drug Designation for eftilagimod alfa for the treatment of Soft Tissue Sarcoma. Unlock hedge fund-leve...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.